MIR503HG silencing promotes endometrial stromal cell progression and metastasis and suppresses apoptosis in adenomyosis by activating the Wnt/ß­catenin pathway via targeting miR­191.

Xu, Xiaoping; Cai, Bin; Liu, Yang; Liu, Ruiqian; Li, Jia

MIR503HG silencing promotes endometrial stromal cell progression and metastasis and suppresses apoptosis in adenomyosis by activating the Wnt/ßcatenin pathway via targeting miR191.

Xu, Xiaoping; Cai, Bin; Liu, Yang; Liu, Ruiqian; Li, Jia.

Afiliação

Xu X; Department of Gynecology, People's Hospital of Deyang City, Deyang, Sichuan 618000, P.R. China.
Cai B; Department of Gynecology, People's Hospital of Deyang City, Deyang, Sichuan 618000, P.R. China.
Liu Y; Department of Gynecology, People's Hospital of Deyang City, Deyang, Sichuan 618000, P.R. China.
Liu R; Department of Gynecology, People's Hospital of Deyang City, Deyang, Sichuan 618000, P.R. China.
Li J; Department of Gynecology, Guizhou Province Maternal and Child Health Hospital, Guiyang, Guizhou 550000, P.R. China.

Exp Ther Med ; 25(3): 117, 2023 Mar.

Article em En | MEDLINE | ID: mdl-36815970